文献速递先天性心脏病外科

基于介电弹性体驱动器的无阀泵作为Fontan失败辅助装置的初步体外研究

Dielectric elastomer actuator-based valveless pump as Fontan failure assist device: introduction and preliminary study.
PubMed 文献 · Interdiscip Cardiovasc Thorac Surg · 2024-01-01

该体外研究在闭环装置中测试了基于介电弹性体驱动器(DEA)和阻抗泵概念的无阀腔肺辅助装置,评估其作为Fontan失败辅助手段的可行性。装置长50 mm、直径30 mm,在4 Hz激活频率下闭环流量可达1.20 L/min,工作内压范围<10至>20 mmHg,且流量特性可通过调节输入信号参数控制。作者认为该无阀阻抗驱动泵在腔肺辅助装置中具有前景,需进一步研究开发。

要点

  • 基于DEA的无阀阻抗驱动泵在体外闭环中可达1.20 L/min流量(4 Hz激活频率)。
  • 装置工作内压范围宽(<10至>20 mmHg),流量方向与大小可由输入信号参数调节。
  • 作者认为该技术作为腔肺辅助装置有前景,需进一步研究开发。

核心结论

  • 作者认为,采用DEA技术的无阀阻抗驱动泵在腔肺辅助装置中具有前景,进一步研究开发可能为右心辅助提供创新且可能更有效的解决方案,尤其针对Fontan失败患者。

研究设计与样本

  • 体外研究:构建基于DEA技术和阻抗泵概念的腔肺辅助装置,在闭环装置中进行测试,以评估其功能与性能。

主要发现

  • 基于DEA的泵长50 mm、直径30 mm,在闭环装置中于4 Hz激活频率下流量可达1.20 L/min。
  • 装置可提供较宽的工作内压范围(<10至>20 mmHg)。
  • 流量特性(方向、大小等)可通过调节输入信号参数(频率、振幅等)控制。

关键数值与推荐

  • 装置尺寸:长50 mm、直径30 mm。
  • 激活频率4 Hz时闭环流量可达1.20 L/min。
  • 工作内压范围<10至>20 mmHg。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Fontan failure refers to a condition in which the Fontan circulation, a surgical procedure used to treat certain congenital heart defects, becomes insufficient, leading to compromised cardiac function and potential complications. This in vitro study therefore investigates the feasibility of bladeless impedance-driven cavopulmonary assist device via dielectric elastomer actuator (DEA) as a means to address Fontan failure. METHODS: A cavopulmonary assist device, constructed using DEA technologies and employing the impedance pump concept, is subjected to in vitro testing within a closed-loop setup. This study aims to assess the device's functionality and performance under controlled conditions, providing valuable insights into its potential application as a cavopulmonary assistive technology. RESULTS: The DEA-based pump, measuring 50 mm in length and 30 mm in diameter, is capable of achieving substantial flow rates within a closed-loop setup, reaching up to 1.20 l/min at an activation frequency of 4 Hz. It also provides a broad range of working internal pressures (<10 to >20 mmHg). Lastly, the properties of the flow (direction, magnitude, etc.) can be controlled by adjusting the input signal parameters (frequency, amplitude, etc.). CONCLUSIONS: In summary, the results suggest that the valveless impedance-driven pump utilizing DEA technology is promising in the context of cavopulmonary assist devices. Further research and development in this area may lead to innovative and potentially more effective solutions for assisting the right heart, ultimately benefiting patients with heart-related health issues overall, with a particular focus on those experiencing Fontan failure.

来源:Interdiscip Cardiovasc Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Benouhiba A, Walter A, Jahren SE, et al. Dielectric elastomer actuator-based valveless pump as Fontan failure assist device: introduction and preliminary study. Interdiscip Cardiovasc Thorac Surg. 2024. PMID: 38514398. doi:10.1093/icvts/ivae041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。